The REACH Intervention for Caregivers of Veterans and Service Members With TBI
Launched by UNIVERSITY OF VIRGINIA · Oct 26, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The REACH Intervention for Caregivers of Veterans and Service Members With Traumatic Brain Injury (TBI) is a study designed to help caregivers who support veterans and service members with TBI. This trial will test a special program called REACH TBI, which aims to reduce stress for caregivers and improve their confidence, mental health, and overall satisfaction with their caregiving experience. The program builds on a successful approach used by the Department of Veterans Affairs to better meet the unique needs of these caregivers.
To participate in this study, caregivers need to be primary caregivers for a veteran or service member who has experienced a TBI at least six months ago. They should have been providing care for at least six months and feel that a significant part of their caregiving relates to TBI. Participants will be randomly assigned to either receive the REACH TBI program or waitlist for it. Throughout the study, caregivers can expect support and resources aimed at improving their caregiving experience. It's important to note that individuals who have certain mental health conditions or who primarily care for issues unrelated to TBI may not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- To be eligible for the study, the participant must:
- • identify as a primary caregiver for a V/SM who sustained a TBI at least 6 months prior;
- • identify as a primary caregiver who has provided care for a V/SM with TBI for at least 6 months;
- • provide some level of daily supervision or assistance with either a physical, cognitive, or behavioral issue they think is likely related to TBI;
- • believe that at least half of their caregiving responsibilities are likely related to TBI rather than another health condition(s); and
- • endorse a score of at least high burden (a score of 8 or higher) on the Zarit Burden Inventory-4.
- Exclusion Criteria:
- • no telephone;
- • current diagnosis of schizophrenia or other major mental illness;
- • auditory impairment that would make telephone use difficult; or
- • the caregiver believes that more than half of their caregiving for the V/SM is for issues related to another health condition(s) rather than TBI.
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported